Investigations of selected historically important syndromic outbreaks: impact and lessons learned for public health preparedness and response.

American Journal of Public Health
Richard A GoodmanTanja Popovic

Abstract

Public health readiness has increased at all jurisdictional levels because of increased sensitivity to threats. Since 2001, with billions of dollars invested to bolster the public health system's capacity, the public expects that public health will identify the etiology of and respond to events more rapidly. However, when etiologies are unknown at the onset of the investigation but interventions must be implemented, public health practitioners must benefit from past investigations' lessons to strengthen preparedness for emerging threats. We have identified such potentially actionable lessons learned from historically important public health events that occurred primarily as syndromes for which the etiological agent initially was unknown. Ongoing analysis of investigations can advance our capability to recognize and investigate syndromes and other problems and implement the most appropriate interventions.

References

Dec 1, 1977·The New England Journal of Medicine·D W FraserP S Brachman
Oct 1, 1978·The Journal of Infectious Diseases·S B ThackerT C Eickhoff
Apr 1, 1979·Annals of Internal Medicine·J E McDadeF M Bozeman
Jun 1, 1977·Annals of Internal Medicine·A C SteereW A Andiman
Jan 1, 1992·Epidemiologic Reviews·E M Kilbourne
Jan 1, 1989·Reviews of Infectious Diseases·P M Schlievert
Mar 1, 1988·Annals of Internal Medicine·G P HolmesS Pahwa
Jul 25, 1986·JAMA : the Journal of the American Medical Association·M T OsterholmP A Blake
Apr 10, 1987·JAMA : the Journal of the American Medical Association·E A Mortimer
Nov 10, 1984·Lancet·K FurushoT Yokoyama
Dec 8, 1983·The New England Journal of Medicine·E M KilbourneA de Carlos
Jan 1, 1983·American Journal of Epidemiology·M T OsterholmW N Hall
Mar 31, 1983·The New England Journal of Medicine·A C SteereS E Malawista
Apr 1, 1981·The Journal of Infectious Diseases·P M SchlievertR D Nishimura
Nov 2, 1995·The New England Journal of Medicine·UNKNOWN Cuba Neuropathy Field Investigation Team
Jul 1, 1993·Clinics in Dermatology·W Burgdorfer
Feb 21, 1996·JAMA : the Journal of the American Medical Association·D KooR Tauxe
Sep 1, 1996·The American Journal of Clinical Nutrition·B A BowmanR M Philen
Mar 25, 1999·Pediatric Cardiology·K B Laupland, H Dele Davies
May 6, 1999·The New England Journal of Medicine·E D BelayL B Schonberger
May 11, 2002·Environmental Health Perspectives·Emilio GelpíUNKNOWN WHO/CISAT Scientific Committee for the Toxic Oil Syndrome. Centro de Investigación para el Síndrome del Aceite Tóxico
Aug 24, 2002·Epidemiologic Reviews·M Posada de la PazA I Borda
Oct 25, 2002·Emerging Infectious Diseases·James M Hughes, Julie Louise Gerberding
Oct 25, 2002·Emerging Infectious Diseases·Daniel B JerniganUNKNOWN National Anthrax Epidemiologic Investigation Team
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Jul 18, 2003·Journal of Medical Microbiology·Peter M HawkeyStephen H Gillespie
Oct 21, 2003·QJM : Monthly Journal of the Association of Physicians·D A GronebergK F Chung
Dec 17, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A BergerW Preiser
Apr 15, 2005·Journal of Public Health Management and Practice : JPHMP·Joseph M PosidBrenda W Garza
Jun 7, 2005·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·David Burgner, Anthony Harnden

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.